المؤلفون: Ratner, E S, Keane, F K, Lindner, R, Tassi, R A, Paranjape, T, Glasgow, M, Nallur, S, Deng, Y, Lu, L, Steele, L, Sand, S, Muller, R-U, Bignotti, E, Bellone, S, Boeke, M, Yao, X, Pecorelli, S, Ravaggi, A, Katsaros, D, Zelterman, D, Cristea, M C, Yu, H, Rutherford, T J, Weitzel, J N, Neuhausen, S L, Schwartz, P E, Slack, F J, Santin, A D, Weidhaas, J B

المصدر: Oncogene ; volume 31, issue 42, page 4559-4566 ; ISSN 0950-9232 1476-5594

الاتاحة: http://dx.doi.org/10.1038/onc.2011.539
https://www.nature.com/articles/onc2011539.pdf
https://www.nature.com/articles/onc2011539

المؤلفون: Ratner, E. S., Keane, F. K., Lindner, R., Tassi, R. A., Paranjape, T., Glasgow, M., Nallur, S., Deng, Y., Lu, L., Steele, L., Sand, S., Muller, R-U, Bignotti, E., Bellone, S., Boeke, M., Yao, X., Pecorelli, S., Ravaggi, A., Katsaros, D., Zelterman, D., Cristea, M. C., Yu, H., Rutherford, T. J., Weitzel, J. N., Neuhausen, S. L., Schwartz, P. E., Slack, F. J., Santin, A. D., Weidhaas, J. B.

مصطلحات موضوعية: ddc:no

Relation: Ratner, E. S., Keane, F. K., Lindner, R., Tassi, R. A., Paranjape, T., Glasgow, M., Nallur, S., Deng, Y., Lu, L., Steele, L., Sand, S., Muller, R-U, Bignotti, E., Bellone, S., Boeke, M., Yao, X., Pecorelli, S., Ravaggi, A., Katsaros, D., Zelterman, D., Cristea, M. C., Yu, H., Rutherford, T. J., Weitzel, J. N., Neuhausen, S. L., Schwartz, P. E., Slack, F. J., Santin, A. D. and Weidhaas, J. B. (2012). A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. Oncogene, 31 (42). S. 4559 - 4567. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5594

الاتاحة: https://kups.ub.uni-koeln.de/48149/

المؤلفون: Ratner, E S, Keane, F K, Lindner, R, Tassi, R A, Paranjape, T, Glasgow, M, Nallur, S, Deng, Y, Lu, L, Steele, L, Sand, S, Muller, R-U, Bignotti, E, Bellone, S, Boeke, M, Yao, X, Pecorelli, S, Ravaggi, A, Katsaros, D, Zelterman, D

المصدر: Oncogene; 10/18/2012, Vol. 31 Issue 42, p4559-4566, 8p, 3 Charts, 5 Graphs

مصطلحات موضوعية: OVARIAN cancer treatment, BIOMARKERS, CANCER genetics, OVARIAN cancer, DRUG therapy, TARGETED drug delivery, DRUG resistance, DRUG synergism, MICRORNA genetics, GENETIC regulation

المؤلفون: Cook, Stephen D., Harding, Amanda F., Morgan, Edward L., Nicholson, Robert J., Thomas, Kevin A., Whitecloud, Thomas S., Ratner, Evan S., Cook, S D, Harding, A F, Morgan, E L, Nicholson, R J, Thomas, K A, Whitecloud, T S, Ratner, E S

المصدر: Journal of Pediatric Orthopaedics; Mar/Apr1987, Vol. 7 Issue 2, p168-174, 7p

المؤلفون: Ratner, E. S., Kin, S. G.

المصدر: Journal of Applied Spectroscopy ; volume 10, issue 4, page 369-371 ; ISSN 0021-9037 1573-8647

الاتاحة: http://dx.doi.org/10.1007/bf00619228
http://link.springer.com/content/pdf/10.1007/BF00619228.pdf
http://link.springer.com/article/10.1007/BF00619228/fulltext.html
http://link.springer.com/content/pdf/10.1007/BF00619228